Innovation Pharmaceuticals Inc.
IPIX · OTC
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $18 | $0 | $423 |
| % Growth | -100% | – | -100% | – |
| Cost of Goods Sold | $373 | $0 | $378 | $0 |
| Gross Profit | -$373 | $18 | -$378 | $423 |
| % Margin | – | 100% | – | 100% |
| R&D Expenses | $1,089 | $4,814 | $6,638 | $2,792 |
| G&A Expenses | $964 | $1,962 | $1,999 | $2,266 |
| SG&A Expenses | $1,477 | $1,962 | $1,999 | $2,266 |
| Sales & Mktg Exp. | $5 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $163 | $0 | $0 |
| Operating Expenses | $2,566 | $6,939 | $8,637 | $5,058 |
| Operating Income | -$3,111 | -$6,921 | -$9,015 | -$4,635 |
| % Margin | – | -38,450% | – | -1,095.7% |
| Other Income/Exp. Net | -$229 | -$120 | -$4,857 | -$2,013 |
| Pre-Tax Income | -$3,168 | -$7,041 | -$13,872 | -$6,648 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3,168 | -$7,041 | -$13,872 | -$6,648 |
| % Margin | – | -39,116.7% | – | -1,571.6% |
| EPS | -0.006 | -0.014 | -0.036 | -0.03 |
| % Growth | 55% | 61% | -21.7% | – |
| EPS Diluted | -0.006 | -0.014 | -0.036 | -0.03 |
| Weighted Avg Shares Out | 505,768 | 503,867 | 386,163 | 237,299 |
| Weighted Avg Shares Out Dil | 505,767 | 503,867 | 386,163 | 237,299 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $4,857 | $0 |
| Interest Expense | $57 | $115 | $4,857 | $260 |
| Depreciation & Amortization | $373 | $382 | $378 | $373 |
| EBITDA | -$2,738 | -$6,544 | -$8,637 | -$6,015 |
| % Margin | – | -36,355.6% | – | -1,422% |